Counterfeit Pharma & the Serialisation Challenge

Rupert Taylor resized.jpg

Counterfeit pharma figures continue to grow due to increasingly complex supply chains, the increased sophistication of counterfeiters, a lack of enforcement capacity, and the expansion of e-commerce, writes Essentra's Rupert Taylor

 ALREADY A REGISTERED USER? SIGN IN now

 

REGISTER FOR FREE TO CONTINUE READING THIS ARTICLE

And get access to unlimited world-class packaging reporting and commentary.